Abbott Laboratories (NYSE:ABT)’s traded shares stood at 0.95 million during the latest session, with the company’s beta value hitting 0.74. At the last check today, the stock’s price was $136.07, to imply an increase of 0.59% or $0.79 in intraday trading. The ABT share’s 52-week high remains $141.23, putting it -3.79% down since that peak but still an impressive 26.72% since price per share fell to its 52-week low of $99.71.
Analysts have given a consensus recommendation of Buy for Abbott Laboratories (ABT), translating to a mean rating of 1.93. Of 13 analyst(s) looking at the stock, 0 analyst(s) give ABT a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 12 recommend it as a Buy.
Abbott Laboratories (NYSE:ABT) trade information
After registering a 0.59% upside in the latest session, Abbott Laboratories (ABT) has traded red over the past five days. The 5-day price performance for the stock is 1.59%, and 5.44% over 30 days. With these gigs, the year-to-date price performance is 20.30%.
The extremes give us $135 and $140 for target low and target high price respectively. As such, ABT has been trading -2.89% off suggested target high and 0.79% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 29.98% for the past 5-year period. While 2025 is set for a 10.51% return in earnings, projections for the next 5 years are at 10.34% annually.
ABT Dividends
Abbott Laboratories has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Abbott Laboratories has a forward dividend ratio of 2.28, with the share yield ticking at 1.68% to continue the rising pattern observed over the past year.
The next major institution holding the largest number of shares is BLACKROCK INC. with 131.13 million shares, or about 7.5619% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $13.63 billion.
